Loading market dashboard
Novo Nordisk A/S
NVOHealthcareNYSEDK
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Novo Nordisk A/S · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $380.54B | $353.47B - $423.39B | $219.82B | $28.866 | 15 |
| Dec 2029 | $356.63B | $331.26B - $396.78B | $206.01B | $26.79 | 15 |
| Dec 2028 | $324.22B | $301.16B - $360.73B | $187.29B | $23.664 | 14 |
| Dec 2027 | $302.80B | $292.57B - $313.63B | $174.92B | $21.772 | 16 |
| Dec 2026 | $295.49B | $287.50B - $304.52B | $170.69B | $21.825 | 16 |
| Dec 2025 | $307.98B | $305.41B - $310.16B | $177.91B | $23.538 | 14 |
| Dec 2024 | $286.12B | $281.03B - $291.21B | $165.28B | $22.585 | 13 |
| Dec 2023 | $226.80B | $221.53B - $232.77B | $105.78B | $18.111 | 3 |
| Dec 2022 | $175.68B | $168.44B - $187.50B | $81.94B | $12.162 | 1 |
| Dec 2021 | $139.79B | $134.02B - $149.19B | $65.20B | $10.304 | 1 |
| Dec 2020 | $125.10B | $119.94B - $133.52B | $58.35B | $8.837 | 2 |
| Dec 2019 | $118.18B | $113.31B - $126.13B | $55.12B | $8.045 | 1 |